Mayo Clinic Doctor Says Mark Cuban’s Cost Plus Drugs is Bringing “Access” to U.S. Healthcare

 

Mark Cuban’s Cost Plus Drugs is making waves in the pharmacy market, gaining more than 1.2 million customers and selling over 1000 generic low-cost drugs at a fraction of the prescription price that Big Pharma puts on the marketplace. The big question now is whether the supply chain can fundamentally shift toward Cuban’s low-cost model as brand-name drugs resist the shift. Assistant Professor of Epidemiology for the Mayo Clinic College of Medicine at Mayo Clinic, Dr. Jose Medina-Inojosa, breaks down the ripple effects from the Cost Plus Drugs approach to drug product logistics.

Dr. Medina-Inojosa’s Thoughts

“Just to give you a little of context, as we all know, we are probably working in the best healthcare system of the world, but one of the major challenges that we have is access, and specifically prescription access is becoming a major problem in the United States. About 18 million people, about 7% of the whole United States, have a lot of trouble accessing medications and this company is probably gonna help some of the problems. They’re based in Dallas, they’re expanding access, they’re negotiating new deals with drug companies, getting access to generic medications that are about 85% cheaper. Talking about, to give you some example for some leukemia medications, it could take a drug from $2,500 to $14 at Mark Cuban’s Cost Plus Drugs, which is extremely exciting.

They’re also working with manufacturing their ordinary prescription medications in Dallas, and I think down the line they’re promising to continue to expand their deals and their reach over the next six or 12 months. So it’s not the major solution to fix all the problems, but I think it’s a really good step in the right direction. And I’m looking forward to see how it will help shape the face of healthcare and how it will help deliver access.”

Follow us on social media for the latest updates in B2B!

Image

Latest

Career
How to Build a Purpose-Driven Career in the Age of AI and Acceleration
October 9, 2025

In a world reshaped by AI, global connectivity, and relentless technological advancement, the pace of disruption has never been greater. Careers are being reinvented as industries transform, and individuals everywhere are being challenged to find meaning, adaptability, and creativity in their professional paths. According to Deloitte’s 2024 Gen Z and Millennial Survey, 86% of Gen…

Read More
youth
Fashion, Identity, and Digital Life Collide: Why Brands Must Listen, Collaborate, and Co-Create With the Next Generation of Youth
October 8, 2025

As the lines blur between fashion, identity, and digital life, brands are racing to understand how today’s youth are reshaping culture and commerce. Pacsun’s new Youth Report 2025, produced in partnership with GlobalData, offers one of the most detailed portraits yet of Gen Z and Gen Alpha—two generations united by self-expression but divided by…

Read More
talent
Grow Your Own Talent: How McDonald’s and Skilltrade Are Building a Culture of Lifelong Learning
October 7, 2025

The world of work is changing faster than ever. Automation is reshaping jobs, new technologies are rewriting what “qualified” means, and a new generation of workers is redefining what they expect from employers. From fast food to healthcare, companies are realizing they can’t just hire talent — they have to build it. They’re starting to…

Read More
The Tesla Test-How AI is Changing How We Search Video
The Tesla Test: How AI is Changing How We Search Video
October 7, 2025

In this episode of Secured, Mike Monsive sits down once again with Idan Koren, EVP of Marketing at Verkada, to discuss how artificial intelligence is transforming the landscape of physical security, operational efficiency, and the broader business of technology. The conversation begins with Verkada’s groundbreaking integration of natural language search in video surveillance —…

Read More